Rural Health Clinical Congress Spring 2022

CME/CE INFORMATION

Rural Health Clinical Congress Spring 2022

Saturday, May 21, 2022 | Virtual Live CME/CE Conference
Broadcast starts at 8:00 AM CT

HOW TO CLAIM CREDIT
In order to obtain your CME/CE certificate(s), please follow the steps below at the conclusion of the event:

Step 1: Log In
Access the event here. At the upper right corner, click Login and enter your username (the email address you used to register for the event) and password.
If you do not know your password, follow the link to reset it.
Step 2: Complete Evaluation(s)
Click the Evaluations tab on the left. You will see a listing of each session. Click the blue Take Evaluation button and complete the evaluation form for each session you attended.
Step 3: View and Print Certificate(s)
After you’ve completed the evaluation(s), click the blue Print Certificate button to view and print your CME/CE certificate(s).

Accelerating Early Detection and Treatment of Diabetic Retinopathy in Rural and Underserved Settings:
Practical Strategies for Improving Patient-Centered Care and Visual Outcomes

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

TARGET AUDIENCE
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.

LEARNING OBJECTIVES

Utilize communication and education strategies to improve compliance with diabetic retinopathy care
Summarize the efficacy and safety of available treatment options for diabetic retinopathy
Examine strategies to improve multidisciplinary care of diabetic retinopathy in rural and underserved communities

FACULTY
Rishi P. Singh, MD
President and Staff Physician
Cleveland Clinic Florida, Martin Health
Stuart, FL
Professor of Ophthalmology
Cleveland Clinic Learner College of Medicine
Cleveland, OH

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.25 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine and RME Collaborative adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies (commercial interests). All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Rishi P. Singh, MD, has disclosed the following relevant financial relationships: consultant/advisory board for Apellis Pharmaceuticals, Inc., Alcon, AsclepiX Therapeutics, LLC, Genentech, Inc., Regeneron Pharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

ACKNOWLEDGEMENT
This program is co-supported by educational grants from AbbVie, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Regeneron Pharmaceuticals, Inc.; Sanofi and Regeneron Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Addressing the Burden of Atopic Dermatitis in Children and Adults:
Strategies for Improving Care and Outcomes in Rural and Underserved Communities

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

LEARNING OBJECTIVES

Explain the pathophysiology and immunologic factors associated with atopic dermatitis
Apply current evidence and recommendations into individualized treatment plans for adult and pediatric patients with atopic dermatitis
Summarize the latest clinical trial data on the efficacy and safety of novel treatment options for atopic dermatitis
Implement strategies to improve multidisciplinary care of atopic dermatitis in rural and underserved communities

FACULTY
Zelma C. Chiesa Fuxench, MD, MSCE
Assistant Professor of Dermatology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Zelma C. Chiesa Fuxench, MD, MSCE, has disclosed the following relevant financial relationships: grant/research support from Eli Lilly and Company; consultant/advisory board for Incyte Corporation.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

COVID-19 Treatment and Prevention in Rural and Underserved Communities:
Integrating the Latest Guidance and Evidence Into Practice

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

LEARNING OBJECTIVES

Integrate available therapies for patients with COVID-19 in the inpatient and outpatient settings
Explain the potential impact of novel variants of SARS-CoV-2 on transmissibility, mortality, and treatment efficacy
Examine the latest clinical and real-world evidence on current and emerging vaccines for COVID-19
Employ multidisciplinary strategies to overcome challenges to treatment and prevention of COVID-19 in rural and underserved settings

FACULTY
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

Faculty

Paul E. Sax, MD, has no relevant financial relationships to disclose.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Patient-Centered Management of Hereditary Angioedema:
Strategies for Improving Care in Rural and Underserved Communities

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

LEARNING OBJECTIVES

Identify symptoms suggestive of hereditary angioedema as well as causes and triggers of attack
Differentiate acute, on-demand therapies, short-term prophylaxis, and long-term prophylaxis for hereditary angioedema
Apply individualized, patient-centered strategies for disease management and monitoring to improve quality of life and patient outcomes
Utilize evidence-based strategies to improve access to care and collaborative management of patients with hereditary angioedema who reside in rural and underserved communities

FACULTY
Marc A. Riedl, MD, MS
Professor of Medicine
Clinical Director – US HAEA Angioedema Center
Clinical Service Chief & Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Marc A. Riedl, MD, MS, has disclosed the following relevant financial relationships: grant/research support from BioMarin Pharmaceutical, Inc., CSL Behring, Ionis Pharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Pharvaris, and Takeda Pharmaceutical Co., Ltd.; speakers’ bureau/honoraria from Grifols, Pharming, and Takeda Pharmaceutical Co., Ltd.; consultant/advisory board member for Astria Therapeutics, Inc., BioCryst Pharmaceuticals, Inc., BioMarin Pharmaceutical, Inc., CSL Behring, Cycle Pharmaceuticals, Ltd., Ipsen, KalVista Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., Pharming, Pharvaris, REGENXBIO, Inc., Sanofi and Regeneron Pharmaceuticals, Inc., and Takeda Pharmaceutical Co., Ltd.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Navigating the Evolving Migraine Treatment Landscape:
A Personalized Approach for Rural and Underserved Settings

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

LEARNING OBJECTIVES

Utilize an evidence-based approach to assess and diagnose patients with migraine
Recognize novel therapeutic options for acute and preventive migraine treatment
Develop a patient-centered treatment plan for migraine tailored to the needs and goals of the individual patient
Discuss strategies to improve multidisciplinary care of diabetic retinopathy in rural and underserved communities

FACULTY
Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, NH
Director, Dartmouth Headache Center
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Stewart J. Tepper, MD, has disclosed the following relevant financial relationships: grant/research support from Allergan/AbbVie, Inc., Amgen, Inc., Eli Lilly and Company, Lundbeck, Neurolief, Inc., Novartis Pharmaceuticals Corporation, Satsuma Pharmaceuticals, Inc., and Zosano Pharma Corporation; consultant/advisory board for AEON BioPharma, Inc., Allergan/AbbVie, Inc., Amgen, Inc., Aruene Corporation, Axsome Therapeutics, Inc., BioDelivery Sciences International, Inc., Biohaven Pharmaceuticals, Inc., ClearView Healthcare Partners, Click Therapeutics, Inc., CoolTech Medical, Eli Lilly and Company, Impel Pharmaceuticals, Inc., Lundbeck, NeuroFront Therapeutics, Ltd., Neurolief, Inc., Novartis Pharmaceuticals Corporation, Palion Medical, PULMATRiX, Inc., Satsuma Pharmaceuticals, Inc., Teva Pharmaceuticals, Theranica Bio-Electronics, Ltd., Tremeau Pharmaceuticals, Inc., Unity HA, Xoc Pharmaceuticals, Inc., and Zosano Pharma Corporation.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

This activity is supported by an educational grant from AbbVie, Inc.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine at inquiries@pimed.com.

COPYRIGHT
©RME Collaborative, a division of Talem Health, LLC 2022. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.